Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches

被引:50
作者
Asati, Vivek [1 ]
Anant, Arjun [1 ]
Patel, Preeti [1 ]
Kaur, Kamalpreet [1 ]
Gupta, G. D. [2 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut Chem, Moga, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India
关键词
Pyrazolo-pyrimidines; Kinase; Targets; SAR; Anticancer; BIOLOGICAL EVALUATION; SELECTIVE INHIBITOR; ANTITUMOR-ACTIVITY; MOLECULAR DOCKING; PHENYL AMIDES; POTENT; DERIVATIVES; CHEMISTRY; ANALOGS; DESIGN;
D O I
10.1016/j.ejmech.2021.113781
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyrazolopyrimidine scaffold is one of the privileged heterocycles in drug discovery. This scaffold produced numerous biological activities in which anticancer is important one. Previous studies showed its importance in interactions with various receptors such as growth factor receptor, TGFBR2 gene, CDK2/cyclin E and Abl kinase, adenosine receptor, calcium-dependent Protein Kinase, Pim-1 kinase, Potent Janus kinase 2, BTK kinase, P21-activated kinase 1, extracellular signal-regulated kinase 2, histone lysine demethylase and Human Kinesin-5. However, there is a need of numerous studies for the discovery of target based potential compounds. The structure activity relationship studies may help to explore the generation of potential compounds in short time period. Therefore, in the present review we tried to explore the structural aspects of Pyrazolopyrimidine with their structure activity relationship against various targets for the development of potential compounds. The current review is the compilation of significant advances made on Pyrazolopyrimidines reported between 2015 and 2020. (C) 2021 Published by Elsevier Masson SAS.
引用
收藏
页数:31
相关论文
共 105 条
[1]   Design, synthesis and antitumor activity of novel pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors [J].
Abdelgawad, Mohamed A. ;
Bakr, Rania B. ;
Alkhoja, Olla A. ;
Mohamed, Wafaa R. .
BIOORGANIC CHEMISTRY, 2016, 66 :88-96
[2]  
Abu Elmaati TM, 2003, J CHIN CHEM SOC-TAIP, V50, P413
[3]   Synthesis of new bi(pyrazolo[1,5-a]pyrimidinyl)-7-one derivatives from dehydroacetic acid and its analogues as antibacterial agents [J].
Aggarwal, Ranjana ;
Rani, Chinu ;
Kumar, Rajiv ;
Garg, Gaurav ;
Sharma, Jitender .
ARKIVOC, 2014, :120-134
[4]   REACTION OF BETA-AMINOCROTONITRILE AND ALPHA-FORMYL PHENYLACETONITRILE WITH HYDRAZINE - SYNTHESIS OF 7-AMINO-[1,5-A]PYRAZOLOPYRIMIDINES [J].
ALCALDE, E ;
MENDOZA, JD ;
GARCIAMA.JM ;
ALMERA, C ;
ELGUERO, J .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1974, 11 (03) :423-429
[5]   Synthesis of pyrazolo[3,4-d]pyrimidin-4(5H)-ones tethered to 1,2,3-triazoles and their evaluation as potential anticancer agents [J].
Allam, Muralidhar ;
Bhavani, A. K. D. ;
Mudiraj, Anwita ;
Ranjan, Nikhil ;
Thippana, Mallikarjuna ;
Babu, Phanithi Prakash .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 156 :43-52
[6]   Synthesis and SAR of a new series of COX-2-selective inhibitors:: Pyrazolo[1,5-α]pyrimidines [J].
Almansa, C ;
de Arriba, AF ;
Cavalcanti, FL ;
Gómez, LA ;
Miralles, A ;
Merlos, M ;
García-Rafanell, J ;
Forn, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (03) :350-361
[7]  
[Anonymous], [No title captured], Patent No. [US4626538, 4626538]
[8]   IMPORTANCE OF HETEROCYCLIC CHEMISTRY: A REVIEW [J].
Arora, Pragi ;
Arora, Varun ;
Lamba, H. S. ;
Wadhwa, Deepak .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (09) :2947-2954
[9]   Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo [1,5-a]pyrimidines as novel larotrectinib analogs [J].
Attia, Mohamed H. ;
Elrazaz, Eman Z. ;
El-Emam, Soad Z. ;
Taher, Azza T. ;
Abdel-Aziz, Hatem A. ;
Abouzid, Khaled A. M. .
BIOORGANIC CHEMISTRY, 2020, 94
[10]   Molecular iodine promoted synthesis of new pyrazolo[3,4-d]pyrimidine derivatives as potential antibacterial agents [J].
Bakavoli, Mehdi ;
Bagherzadeh, Ghodsieh ;
Vaseghifar, Maryam ;
Shiri, Ali ;
Pordel, Mehdi ;
Mashreghi, Mansour ;
Pordeli, Parvaneh ;
Araghi, Maryam .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (02) :647-650